Exosomes are lipid bilayer membrane vesicles and are emerging as competent
nanocarriers for drug delivery. The clinical translation of exosomes faces many challenges …

Extracellular vesicles (EVs) have emerged as promising candidates for multiple biomedical
applications. Major types of EVs include exosomes, microvesicles, and apoptotic bodies …

It has been observed that many phytochemicals, frequently present in foods or beverages,
show potent chemopreventive or therapeutic properties that selectively affect cancer cells …

Pancreatic cancer remains one of the most highly lethal diseases with very poor prognosis.
Gemcitabine (GEM) is the first-line chemotherapeutic drug for pancreatic cancer treatment …

Extracellular vesicles (EVs) are nanovesicles involved in multiple biological functions. Small
EVs (sEVs) are emerging as therapeutics and drug delivery systems for their contents …

Exosomes (Exos) are promising vehicles for brain drug delivery due to nanosize and the
ability to breach the blood–brain barrier (BBB). But the low yield of natural exosomes limits …

Bacterial outer membrane vesicles (OMVs) are potent immuno-stimulating agents and have
the potentials to be bioengineered as platforms for antitumor nanomedicine. In this study …

Targeted drug delivery to the glioblastoma (GBM) overcoming blood–brain barrier (BBB) has
been challenging. Exosomes are promising vehicles for brain tumor drug delivery, but the …

Extracellular vesicles (EVs) are cell-derived lipid bilayer-enclosed nanovesicles. EVs are
emerging as keys for identifying molecular mechanisms by mediating intercellular …

Antisense oligonucleotides (ASOs) are an important tool for the treatment of many genetic
disorders. However, similar to other gene drugs, vectors are often required to protect them …